Heart Test Laboratories, Inc. HSCS 深 沪
等待开盘 10-02 09:30:00 美东时间
3.4842
+0.004
+0.12%
华盛通- 最 高3.5299
- 今 开3.44
- 成交量 8374股
- 最 低 3.44
- 昨 收 3.48
- 总市值 673.95万
- 52周最高 6.47
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 2.5164
- 委 比 -60.00%
- 总股本 193.43万
- 历史最高 600.00
- 量 比 0.14
- 振 幅 2.58%
- 历史最低 2.62
- 每 手 1
- 风险率 6.61%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Ascendiant Capital Maintains Buy on HeartSciences, Lowers Price Target to $9
Ascendiant Capital analyst Lucas Ward maintains HeartSciences (NASDAQ:HSCS) with a Buy and lowers the price target from $15 to $9.
10-01 18:27
Heart Test Laboratories Regains Nasdaq Compliance
Heart Test Laboratories, Inc. ( ($HSCS) ) has provided an update. On September ...
09-18 05:22
HeartSciences GAAP EPS of -$1.58
HeartSciences press release (NASDAQ:HSCS): Q1 GAAP EPS of -$1.58. More on HeartSciences Seeking Alpha’s Quant Rating on HeartSciences Historical earnings data for HeartSciences Financial information f...
09-13 01:39
Heart Test Laboratories Q1 EPS $(1.58) Beats $(2.09) Estimate, Sales $1.900M
Heart Test Laboratories (NASDAQ:HSCS) reported quarterly losses of $(1.58) per share which beat the analyst consensus estimate of $(2.09) by 24.4 percent. This is a 40.15 percent increase over losses of $(2.64) per share
09-12 04:19
HeartSciences Announces Conference Participation and Investor Webinar
HeartSciences Inc., a medical technology company using AI to enhance ECGs for heart disease detection, is participating in virtual events in August. On August 20, 2025, they will host an investor webinar at 2:00 p.m. ET and present at the Emerging Growth Conference 85 at 3:10 p.m. ET. Both events aim to introduce their technology and updates. The webinar and conference presentation are open to all interested parties, with links provided for regis...
08-15 13:00
央企重组整合密集落地，恒生央企ETF(513170)上涨近1%
截至2025年8月7日13:44，恒生央企ETF(513170)上涨0.62%，最新价报1.46元。 消息面上，中国神华、中国船舶、中化系等央企密集...
08-07 13:56
Heart Test Laboratories Q4 EPS $(1.86) Beats $(2.25) Estimate, Sales $4.350M
Heart Test Laboratories (NASDAQ:HSCS) reported quarterly losses of $(1.86) per share which beat the analyst consensus estimate of $(2.25) by 17.33 percent. The company reported $4.350 million in sales this quarter.
07-25 04:32
HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results
HeartSciences Inc. reported its fiscal year 2025 financial results and business progress, highlighting advancements in its AI-powered ECG technology. The company launched the MyoVista Insights software platform, a cloud-native solution designed to modernize ECG management systems and integrate AI algorithms. The MyoVista wavECG device nearing FDA submission, and the company secured reimbursement for AI-ECG algorithms and a Breakthrough Device des...
07-24 20:15
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Medpace Hldgs (NASDAQ:MEDP) shares moved upwards by 44.6% to $446.6 du...
07-22 20:07
